International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC
March 07, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - March 07, 2016) - International Stem Cell Corporation (OTCQB: ISCO), a clinical stage biotechnology company developing novel stem cell-based therapies, announced...
International Stem Cell Corporation Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health
December 23, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - December 23, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a clinical stage biotechnology company developing novel stem...
International Stem Cell Corporation Receives Authorization to Initiate Phase I/IIa Clinical Trial of ISC-hpNSC for the Treatment of Parkinson's Disease
December 14, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - December 14, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a leader in using pluripotent stem cells in regenerative medicine, announced today that the...
International Stem Cell Corporation Announces Launch Plans for New Nano-Compound Products
December 01, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - December 01, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical...
International Stem Cell Corporation Announces Operating Results for the Three- and Nine-Months Ended September 30, 2015
November 16, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - November 16, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company...
International Stem Cell Corporation Moves Forward With Parkinson's Disease Clinical Trials in Australia
November 03, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - November 03, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical...
International Stem Cell Corporation Presents Comprehensive Findings for Parkinson's Disease Program Preclinical Studies at the Society for Neuroscience Annual Meeting, Neuroscience 2015
October 14, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - October 14, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical...
International Stem Cell Corporation Develops Technology to Replace Cartilage for the Treatment of Osteoarthritis
September 30, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - September 30, 2015) - International Stem Cell Corporation (OTCQB: ISCO)(www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company...
International Stem Cell Names Ms. Ebrahimi as Chief Financial Officer
September 22, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - September 22, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company...
International Stem Cell Corporation Announces Next Phase of Research Collaboration With Rohto Pharmaceutical Co., Ltd. of Japan
September 08, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - September 08, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company...